These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1580062)

  • 21. Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate).
    Stadler M; Gruber G; Kannicht C; Biesert L; Radomski KU; Suhartono H; Pock K; Neisser-Svae A; Weinberger J; Römisch J; Svae TE
    Biologicals; 2006 Dec; 34(4):281-8. PubMed ID: 16500114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Functionality of von Willebrand factor present in Fanhdi: adhesion to the vascular subendothelium in vitro].
    Escolar G; Viñas M; Pino M; Casamiquela R; Jorquera JI
    Sangre (Barc); 1997 Oct; 42(5):377-81. PubMed ID: 9424737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems.
    Burnouf T; Caron C; Radosevich M; Goubran HA; Goudemand J; El-Ekiaby M
    Haemophilia; 2008 Sep; 14(5):956-62. PubMed ID: 18565126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat-treated factor VIII/von Willebrand factor concentrate in platelet-type von Willebrand's disease.
    Takahashi H; Tatewaki W; Nagayama R; Hanano M; Tamura M; Yamaguchi T; Takizawa S; Wada K; Shibata A
    Haemostasis; 1987; 17(6):353-60. PubMed ID: 3123334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evaluation of a very-high-purity, solvent/detergent-treated, von Willebrand factor concentrate.
    Mazurier C; Jorieux S; de Romeuf C; Samor B; Goudemand M
    Vox Sang; 1991; 61(1):1-7. PubMed ID: 1949703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoaffinity purification of factor VIII complex.
    Hornsey VS; Griffin BD; Pepper DS; Micklem LR; Prowse CV
    Thromb Haemost; 1987 Feb; 57(1):102-5. PubMed ID: 3109055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction of the factor VIII/von Willebrand factor complex (VIII/vWf), with guanidinium-derivatized matrices.
    Saundry RH; Savidge GF
    Bioseparation; 1991; 2(3):177-86. PubMed ID: 1368084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of human elastase on von Willebrand factor in highly purified factor VIII concentrate and in cryoprecipitate.
    Jeleńska M; Bykowska W; Kopeć M; Vigh Z; Scharrer I; Breddin K
    Thromb Res; 1990 Jul; 59(2):295-307. PubMed ID: 2122538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of factor VIII and von Willebrand factor from human plasma by anion-exchange chromatography.
    Josic D; Schwinn H; Stadler M; Strancar A
    J Chromatogr B Biomed Appl; 1994 Dec; 662(2):181-90. PubMed ID: 7719474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A very-high-purity von Willebrand factor preparation containing high-molecular-weight multimers.
    Barington KA; Kaersgaard P
    Vox Sang; 1999; 76(2):85-9. PubMed ID: 10085524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity.
    Goudemand J; Mazurier C; Marey A; Caron C; Coupez B; Mizon P; Goudemand M
    Br J Haematol; 1992 Feb; 80(2):214-21. PubMed ID: 1550779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM; Goy C; Budek I; Seitz R
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary results on the carbohydrate moiety of factor VIII/von Willebrand factor (FVIII/vWf).
    Samor B; Mazurier C; Goudemand M; Debeire P; Fournet B; Montreuil J
    Thromb Res; 1982 Jan 1-15; 25(1-2):81-9. PubMed ID: 6801813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of a new highly pure, double virus inactivated von Willebrand factor concentrate.
    Mori F; Maddaluno M; Farina C
    Blood Coagul Fibrinolysis; 2018 Jan; 29(1):30-38. PubMed ID: 28957942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
    Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
    Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women.
    Tanaka KA; Bharadwaj S; Hasan S; Judd M; Abuelkasem E; Henderson RA; Chow JH; Williams B; Mazzeffi MA; Crimmins SD; Malinow AM
    Br J Anaesth; 2019 Jun; 122(6):751-759. PubMed ID: 30916034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of factor VIII/von Willebrand factor protein (F VIII/vWF) and F VIII/vWF-poor cryoprecipitate on post-ischemic microvascular reperfusion in the central nervous system.
    Hallenbeck JM; Furlow TW; Gralnick HR
    Stroke; 1981; 12(1):93-7. PubMed ID: 6784287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease.
    Favaloro EJ; Thom J; Patterson D; Just S; Baccala M; Dixon T; Meiring M; Koutts J; Rowell J; Baker R
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):475-83. PubMed ID: 19584715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.